Prabaha007 (Talk | contribs) |
Prabaha007 (Talk | contribs) |
||
Line 140: | Line 140: | ||
<h3>Overview</h3> | <h3>Overview</h3> | ||
</div> | </div> | ||
− | + | ||
<div class="row"> | <div class="row"> | ||
<div class="refer col-md-6"> | <div class="refer col-md-6"> | ||
Line 157: | Line 157: | ||
<h3>Our Bioreactor Design</h3> | <h3>Our Bioreactor Design</h3> | ||
</div> | </div> | ||
− | + | ||
<div class="row"> | <div class="row"> | ||
<div class="refer col-md-6"> | <div class="refer col-md-6"> |
Revision as of 21:16, 19 October 2016
Overview
With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1].
Read more